Bahl & Gaynor Inc. Sells 15,108 Shares of Amdocs Limited (NASDAQ:DOX)

Bahl & Gaynor Inc. trimmed its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 3.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 431,673 shares of the technology company’s stock after selling 15,108 shares during the period. Bahl & Gaynor Inc. owned about 0.38% of Amdocs worth $36,753,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. First Horizon Advisors Inc. increased its position in Amdocs by 1.9% in the third quarter. First Horizon Advisors Inc. now owns 5,902 shares of the technology company’s stock worth $516,000 after buying an additional 109 shares during the last quarter. Private Trust Co. NA grew its stake in shares of Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after acquiring an additional 117 shares during the period. Principal Securities Inc. raised its stake in Amdocs by 10.4% in the 4th quarter. Principal Securities Inc. now owns 1,341 shares of the technology company’s stock valued at $114,000 after acquiring an additional 126 shares during the period. Morton Community Bank lifted its holdings in Amdocs by 0.4% during the third quarter. Morton Community Bank now owns 36,410 shares of the technology company’s stock valued at $3,185,000 after purchasing an additional 130 shares during the last quarter. Finally, Private Advisor Group LLC lifted its holdings in Amdocs by 3.2% during the third quarter. Private Advisor Group LLC now owns 5,626 shares of the technology company’s stock valued at $492,000 after purchasing an additional 175 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Barclays lowered their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research report on Thursday, November 14th. Oppenheimer boosted their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Finally, StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.20.

Amdocs Trading Down 0.5 %

NASDAQ DOX opened at $86.82 on Tuesday. The stock has a market cap of $9.80 billion, a P/E ratio of 20.14, a price-to-earnings-growth ratio of 1.47 and a beta of 0.71. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The stock has a 50 day simple moving average of $86.22 and a two-hundred day simple moving average of $86.86. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be given a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a yield of 2.43%. This is a boost from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. Amdocs’s payout ratio is presently 48.72%.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.